左氧氟沙星在结核性渗出性胸膜炎患者临床治疗中应用的价值研究
详细信息 查看官网全文
- 论文作者：贺婷婷 ; 武涧松
- 年：2017
- 作者机构：火箭军总医院;
- 论文关键词：左氧氟沙星 ; 结核性渗出性胸膜炎 ; 吡嗪酰胺
- 英文论文关键词：levofloxacin ; tuberculous exudative pleurisy ; pyrazinamide
- 会议召开时间：2017-05-26
- 会议录名称：2017年《中国组织化学与细胞化学杂志》临床研讨会论文集
- 语种：中文
- 分类号：R521.7
- 学会代码：ZHXB
- 会议名称：2017年《中国组织化学与细胞化学杂志》临床研讨会
- 会议地点：中国湖北武汉
- 主办单位：《中国组织化学与细胞化学杂志》社有限公司
- 学会名称：《中国组织化学与细胞化学杂志》社有限公司
- 页数：1
- 文件大小：129k
- 原文格式：O
- 会议级别：全国
摘要
目的:探究结核性渗出性胸膜炎患者接受左氧氟沙星治疗的价值。方法:选取胸膜炎患者60例,时间为2015年8月-2016年9月,这60例胸膜炎患者均为结核性渗出性疾病。根据患者治疗方法的不同分为2组,其中对照组给予吡嗪酰胺化疗方案治疗,实验组给予左氧氟沙星化疗方案治疗,对比2组胸膜炎患者治疗结果的差异性。结果:实验组胸膜炎患者治疗的总有效率(96.67%)与对照组治疗的总有效率(93.33%)相比,差异较小,P>0.05;2组胸膜炎患者的胸水吸收时间相比,差异较小(P>0.05);实验组胸膜炎患者的不良反应发生情况与对照组相比,差异明显(P<0.05)。结论:结核性渗出性胸膜炎患者接受左氧氟沙星治疗,疗效显效,副作用少,具有较高的应用价值。
Objectivet:To investigate the value of levofloxacin in patients with tuberculous exudative pleurisy.Methods:Sixty patients with pleurisy were enrolled in this study.From September,2008 to September 2016,60 patients with pleurisy were tuberculous exudative diseases.According to the different treatment Methods:of patients divided into two groups,of which the control group was treated with pyrazinamide chemotherapy regimen,the experimental group was treated with levofloxacin chemotherapy regimen,compared with the two groups of patients with pleural effusion treatment differences.Results:The total effective rate(96.67%) in the treatment group was significantly lower than that in the control group(93.33%).The difference was significant(P>0.05)(P>0.05).The incidence of adverse events in the experimental group was significantly different from that in the control group(P<0.05).Conclusion:Patients with tuberculous exudative pleurisy are treated with levofloxacin,the curative effect is effective and the side effect is low,which has high application value.
Objectivet:To investigate the value of levofloxacin in patients with tuberculous exudative pleurisy.Methods:Sixty patients with pleurisy were enrolled in this study.From September,2008 to September 2016,60 patients with pleurisy were tuberculous exudative diseases.According to the different treatment Methods:of patients divided into two groups,of which the control group was treated with pyrazinamide chemotherapy regimen,the experimental group was treated with levofloxacin chemotherapy regimen,compared with the two groups of patients with pleural effusion treatment differences.Results:The total effective rate(96.67%) in the treatment group was significantly lower than that in the control group(93.33%).The difference was significant(P>0.05)(P>0.05).The incidence of adverse events in the experimental group was significantly different from that in the control group(P<0.05).Conclusion:Patients with tuberculous exudative pleurisy are treated with levofloxacin,the curative effect is effective and the side effect is low,which has high application value.
引文
[1]王丽莉.抗结核药物联合左氧氧沙星治疗结核性胸膜炎效果及安全性评价[J].临床合理用药杂志,2015,8(5):62-63.
[2]刘春燕,郭乐,杜鹃等.短疗程与长疗程左氧氧沙星联合尿激酶胸腔注射治疗结核性胸膜炎的疗效比较[J].药物评价研究,2016,39(6):1039-1042.
[3]李燕平.左氧氧沙星联合抗结核药治疗复治结核性胸膜炎的疗效观察[J].中国社区医师,2016,32(33):34-34,36.
[4]朱红艳.不同疗程左氧氧沙星联合四联抗结核疗法治疗结核性胸膜炎的临床疗效研究[J].实用心脑肺血管病杂志,2015,23(12):96-98.
[5]宋淑清.左氧氧沙星联合异烟肼治疗结核性胸膜炎疗效分析[J].临床医药文献电子杂志,2016,3(12):2412-2412,2413.
[2]刘春燕,郭乐,杜鹃等.短疗程与长疗程左氧氧沙星联合尿激酶胸腔注射治疗结核性胸膜炎的疗效比较[J].药物评价研究,2016,39(6):1039-1042.
[3]李燕平.左氧氧沙星联合抗结核药治疗复治结核性胸膜炎的疗效观察[J].中国社区医师,2016,32(33):34-34,36.
[4]朱红艳.不同疗程左氧氧沙星联合四联抗结核疗法治疗结核性胸膜炎的临床疗效研究[J].实用心脑肺血管病杂志,2015,23(12):96-98.
[5]宋淑清.左氧氧沙星联合异烟肼治疗结核性胸膜炎疗效分析[J].临床医药文献电子杂志,2016,3(12):2412-2412,2413.